SVX-1

N/A

Report date: 2022/11/27 16:44:56

Base Information

Drug NameSVX-1
Drug Alias NameSurvivin Immunotherapy-1SVX-1
ClassificationVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder NeoplasmsKidney NeoplasmsProstatic Neoplasms +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVaxeal Holding SA
China Registration ClassN/A

Develop Information

Active CompaniesVaxeal Holding SA
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsKidney NeoplasmsProstatic Neoplasms +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A